Moderna's $2.25 Billion Settlement Boosts Shares and Clears Vaccine Path

Moderna's $2.25 Billion Settlement Boosts Shares and Clears Vaccine Path

How This Puts Money in Your Pocket If you hold biotech stocks, Moderna's $2.25 billion settlement with Arbutus Biopharma and Genevant could affect y...